Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study

The tumour-stroma ratio (TSR) and tumour budding (TB) are two high-risk factors with potential to be implemented in the next TNM classification. The aim of the current study was to evaluate the practical application of the two biomarkers based on reproducibility, independency and prognostic value. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit, Marloes A., van Pelt, Gabi W., Terpstra, Valeska, Putter, Hein, Tollenaar, Rob A. E. M., Mesker, Wilma E., van Krieken, J. Han J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589816/
https://www.ncbi.nlm.nih.gov/pubmed/34533595
http://dx.doi.org/10.1007/s00384-021-04023-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589816/
https://www.ncbi.nlm.nih.gov/pubmed/34533595
http://dx.doi.org/10.1007/s00384-021-04023-4

Ejemplares similares